litlas
Log inCreate account

Pedram Razavi

Active 2009–2026

109
Papers
23,242
Citations
51
h-index
97
i10-index

Citations

Citations per year for Pedram Razavi1976: 1 citations1977: 1 citations1992: 1 citations1998: 2 citations2004: 1 citations2009: 2 citations2010: 9 citations2011: 22 citations2012: 25 citations2013: 27 citations2014: 41 citations2015: 28 citations2016: 38 citations2017: 81 citations2018: 152 citations2019: 752 citations2020: 1,265 citations2021: 1,391 citations2022: 1,154 citations2023: 1,008 citations2024: 1,345 citations2025: 917 citations2026: 325 citations1978–1991: no citations, so these years are not shown1993–1997: no citations, so these years are not shown1999–2003: no citations, so these years are not shown2005–2008: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,379 citing papers, 28.9% of this breakdownChina: 1,690 citing papers, 14.5% of this breakdownUnited Kingdom: 653 citing papers, 5.6% of this breakdownItaly: 613 citing papers, 5.2% of this breakdownGermany: 512 citing papers, 4.4% of this breakdownFrance: 418 citing papers, 3.6% of this breakdownCanada: 378 citing papers, 3.2% of this breakdownSpain: 373 citing papers, 3.2% of this breakdownJapan: 323 citing papers, 2.8% of this breakdownAustralia: 296 citing papers, 2.5% of this breakdownNetherlands: 284 citing papers, 2.4% of this breakdownSwitzerland: 259 citing papers, 2.2% of this breakdown
0%28.9%Other 21.5%

Institutions

Fields

  • Medicine50.6%
  • Biochemistry, Genetics and Molecular Biology35.1%
  • Computer Science6%
  • Engineering2.8%
  • Immunology and Microbiology2.5%
  • Neuroscience0.8%
  • Other2.2%

Topics

  • Cancer Genomics and Diagnostics8.7%
  • Cancer Immunotherapy and Biomarkers6.3%
  • Lung Cancer Treatments and Mutations3.9%
  • Advanced Breast Cancer Therapies2.4%
  • Ferroptosis and cancer prognosis2.3%
  • Genetic factors in colorectal cancer2.1%
  • Other74.3%

Coauthors

All papers

Open in search
  1. τ-bench: A Benchmark for Tool-Agent-User Interaction in Real-World Domains

    Authors: Shunyu Yao, Noah Shinn, Pedram Razavi, Karthik Narasimhan - arXiv (Cornell University), CoRR 2024 cited by 456

  2. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Authors: Ahmet Zehir, Ryma Benayed, Ronak Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M. Devlin, Matthew D. Hellmann, David Barron, Alison M. Schram, Meera Hameed, Snjezana Doğan, Dara S. Ross, Jaclyn F. Hechtman, Deborah F. DeLair, JinJuan Yao, Diana Mandelker, Donavan T. Cheng, Raghu Chandramohan, Abhinita Mohanty, Ryan Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa Syed, Anoop Balakrishnan Rema, Zhen Y. Liu, Khédoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 cited by 3,517

  4. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  5. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    Authors: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 cited by 1,006

  6. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

    Authors: Pedram Razavi, Bob T. Li, David N. Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino de Bruijn, Chenlu Hou, Oliver Venn, Raymond S. Lim, Aseem Anand, Tara Maddala, Sante Gnerre, Ravi Vijaya Satya, Qin‐Wen Liu, Ling Shen, Nicholas Eattock, Jeanne Yue, Alexander W. Blocker, Mark Lee, Amy J. Sehnert, Hui Xu, Megan P. Hall, Angie Santiago-Zayas, William Novotny, James M. Isbell, Valerie W. Rusch, George Plitas, Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho - Nature Medicine 2019 cited by 767

  7. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    Authors: Zhiqiang Li, Pedram Razavi, Qing Li, Weiyi Toy, Bo Liu, Christina Ping, Wilson C. Hsieh, Francisco Sánchez-Vega, David N. Brown, Arnaud Da Cruz Paula, Luc G.T. Morris, Pier Selenica, Emily M. Eichenberger, Ronglai Shen, Nikolaus Schultz, Neal Rosen, Maurizio Scaltriti, Edi Brogi, José Baselga, Jorge S. Reis‐Filho, Sarat Chandarlapaty - Cancer Cell 2018 cited by 521

  8. Genome doubling shapes the evolution and prognosis of advanced cancers

    Authors: Craig M. Bielski, Ahmet Zehir, Alexander Penson, Mark T.A. Donoghue, Walid K. Chatila, Joshua Armenia, Matthew T. Chang, Alison M. Schram, Philip Jonsson, Chaitanya Bandlamudi, Pedram Razavi, Gopa Iyer, Mark E. Robson, Zsofia K. Stadler, Nikolaus Schultz, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Barry S. Taylor - Nature Genetics 2018 cited by 692

  9. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    Authors: Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai‐Yan Tu, Mackenzie L. Myers, Chong‐Rui Xu, Marissa S. Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhem, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U. Lin, David B. Solit, Michael F. Berger, Paul R. Barber, Tony Ng, Michael Offin, James M. Isbell, David R. Jones, Helena A. Yu, Sheeno Thyparambil, Wei‐Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 cited by 289

  10. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    Authors: Justin Jee, Emily S. Lebow, Randy Yeh, Jeeban P. Das, Azadeh Namakydoust, Paul K. Paik, Jamie E. Chaft, Gowtham Jayakumaran, A. Rose Brannon, Ryma Benayed, Ahmet Zehir, Mark T.A. Donoghue, Nikolaus Schultz, Debyani Chakravarty, Ritika Kundra, Ramyasree Madupuri, Yonina R. Murciano‐Goroff, Hai‐Yan Tu, Chong‐Rui Xu, Andrés Martinez, Clare Wilhelm, Jesse Galle, Bobby Daly, Helena A. Yu, Michael Offin, Matthew D. Hellmann, Piro Lito, Kathryn C. Arbour, Marjorie G. Zauderer, Mark G. Kris, Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185

  11. Accelerating Discovery of Functional Mutant Alleles in Cancer

    Authors: Matthew T. Chang, Tripti Shrestha Bhattarai, Alison M. Schram, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Debyani Chakravarty, Sarah Phillips, Cyriac Kandoth, Alexander Penson, Alexander N. Gorelick, Tambudzai Shamu, Swati Patel, Christopher Harris, Jianjiong Gao, S. Onur Sumer, Ritika Kundra, Pedram Razavi, Bob T. Li, Dalicia N. Reales, Nicholas D. Socci, Gowtham Jayakumaran, Ahmet Zehir, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Marc Ladanyi, Nikolaus Schultz, José Baselga, Michael F. Berger, Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 cited by 426

  12. Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

    Authors: Neil Vasan, Pedram Razavi, Jared L. Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander N. Gorelick, Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T. Chang, Barry S. Taylor, Maura N. Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raúl Rabadán, Ed Reznik, Melissa Smith, Robert Sebra, Frauke Schimmöller, Timothy R. Wilson, Lori S. Friedman, Lewis C. Cantley, Maurizio Scaltriti, José Baselga - Science 2019 cited by 295

  13. Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists

    Authors: Weiyi Toy, Hazel M. Weir, Pedram Razavi, Mandy Lawson, Anne U. Goeppert, Anne Marie Mazzola, Aaron Smith, Joanne Wilson, Christopher J. Morrow, Wai Lin Wong, Elisa de Stanchina, Kathryn E. Carlson, Teresa S. Martin, Sharmeen Uddin, Zhiqiang Li, Sean W. Fanning, John A. Katzenellenbogen, Geoffrey L. Greene, José Baselga, Sarat Chandarlapaty - Cancer Discovery 2016 cited by 370

  14. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

    Authors: Qing Li, Baishan Jiang, Jiaye Guo, Hong Shao, Isabella Del Priore, Qing Chang, Rei Kudo, Zhiqiang Li, Pedram Razavi, Bo Liu, Andrew S. Boghossian, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, Katherine A. Donovan, Marta Palafox, Jorge S. Reis‐Filho, Elisa de Stanchina, Eric S. Fischer, Neal Rosen, Violeta Serra, Andrew Koff, John D. Chodera, Nathanael S. Gray, Sarat Chandarlapaty - Cancer Discovery 2021 cited by 165

  15. Automated real-world data integration improves cancer outcome prediction

    Authors: Justin Jee, Christopher J. Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra, Michele Waters, Chenlian Fu, Mirella L. Altoé, Siyang Liu, Steven B. Maron, Mehnaj Ahmed, Susie Kim, Mono Pirun, Walid K. Chatila, Ino de Bruijn, Arfath Pasha, Ritika Kundra, Benjamin Groß, Brooke Mastrogiacomo, Tyler Aprati, David Liu, Jianjiong Gao, Marzia Capelletti, Kelly R. Pekala, Lisa Loudon, Maria Perry, Chaitanya Bandlamudi, Mark T.A. Donoghue, Baby A. Satravada, Axel Martin, Ronglai Shen, Yuan Chen, A. Rose Brannon, Jason C. Chang, Lior Z. Braunstein, Anyi Li, Anton Safonov, Aaron J. Stonestrom, Pablo Sánchez Vela, Clare Wilhelm, Mark E. Robson, Howard I. Scher, Marc Ladanyi, Jorge S. Reis‐Filho, David B. Solit, David R. Jones, Daniel R. Gomez, Helena A. Yu, Debyani Chakravarty, Rona Yaeger, Wassim Abida, Wungki Park, Eileen M. O’Reilly, Julio García‐Aguilar, Nicholas D. Socci, Francisco Sánchez-Vega, Jian Carrot‐Zhang, Peter D. Stetson, Ross L. Levine, Charles M. Rudin, Michael F. Berger, Sohrab P. Shah, Deborah Schrag, Pedram Razavi, Kenneth L. Kehl, Bob T. Li, Gregory J. Riely, Nikolaus Schultz, MSK Cancer Data Science Initiative Group, Aaron Lisman, Gaofei Zhao, Ino de Bruijn, Walid K. Chatila, Xiang Li, Aarman Kohli, Darin Moore, Raymond Lim, Tom Pollard, Robert E. Sheridan, Avery Wang, Calla Chennault, Manda Wilson, Hongxin Zhang, Robert Pimienta, Surya Narayana Rangavajhala, Guru Subramanian, J.A. Valverde García, Naveen Rachuri, Kevin Boehm, Mitchell I. Parker, Henry Walch, Subhiksha Nandakumar, Jordan Eichholz, Ayush Kris, Paolo Manca, Xuechun Bai, Tejiri Agbamu, U Justin, Xiao-Jun Bi - Nature 2024 cited by 154

  16. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. lacobuzio-Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69

  17. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role

    Authors: Maxwell R. Lloyd, Seth A. Wander, Erika Hamilton, Pedram Razavi, Aditya Bardia - Therapeutic Advances in Medical Oncology 2022 cited by 99

  18. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

    Authors: Guotai Xu, Sagar Chhangawala, Emiliano Cocco, Pedram Razavi, Yanyan Cai, Jordan E. Otto, Lorenzo Ferrando, Pier Selenica, Erik Ladewig, Carmen Chan, Arnaud Da Cruz Paula, Matthew D. Witkin, Yuanming Cheng, Jane Park, Cristian Serna‐Tamayo, HuiYong Zhao, Fan Wu, Mirna Sallaku, Xuan Qu, Alison Zhao, Clayton K. Collings, Andrew R. D’Avino, Komal Jhaveri, Richard P. Koche, Ross L. Levine, Jorge S. Reis‐Filho, Cigall Kadoch, Maurizio Scaltriti, Christina S. Leslie, José Baselga, Eneda Toska - Nature Genetics 2020 cited by 240

  19. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

    Authors: A. Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu, Fanli Meng, Mohammad Mahfuzul Haque, Justyna Sadowska, Brian J. Murphy, Tessara Baldi, Ian Johnson, Ryan Ptashkin, Maysun Hasan, Preethi Srinivasan, Anoop Balakrishnan Rema, Ivelise Rijo, Aaron Agarunov, Helen Won, D. S. Perera, David N. Brown, Aliaksandra Samoila, Xiaohong Jing, Erika Gedvilaite, Julie L. Yang, Dennis Stephens, Jenna-Marie Dix, Nicole DeGroat, Khédoudja Nafa, Aijazuddin Syed, Alan Li, Emily S. Lebow, Anita S. Bowman, Donna C. Ferguson, Ying Liu, Douglas A. Mata, Rohit Sharma, Soo‐Ryum Yang, Tejus Bale, Jamal Benhamida, Jason C. Chang, Snjezana Doğan, Meera Hameed, Jaclyn F. Hechtman, Christine Moung, Dara S. Ross, Efsevia Vakiani, Chad Vanderbilt, JinJuan Yao, Pedram Razavi, Lillian M. Smyth, Sarat Chandarlapaty, Gopa Iyer, Wassim Abida, James J. Harding, Benjamin A. Krantz, Eileen M. O’Reilly, Helena A. Yu, Bob T. Li, Charles M. Rudin, Luis A. Díaz, David B. Solit, Maria E. Arcila, Marc Ladanyi, Brian Houck‐Loomis, Dana W.Y. Tsui, Michael F. Berger, Ahmet Zehir, Ryma Benayed - Nature Communications 2021 cited by 183

  20. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    Authors: Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff - Nature Medicine 2022 cited by 129

  21. Nanowire transistors without junctions

    Authors: Jean-Pierre Colinge, Chi‐Woo Lee, Aryan Afzalian, Nima Dehdashti Akhavan, Ran Yan, Isabelle Ferain, Pedram Razavi, B. O'Neill, Alan Blake, Mary White, Anne-Marie Kelleher, Brendan McCarthy, Richard Murphy - Nature Nanotechnology 2010 cited by 2,367

  22. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

    Authors: Pedram Razavi, Maura N. Dickler, Payal D. Shah, Weiyi Toy, David N. Brown, Helen Won, Bob T. Li, Ronglai Shen, Neil Vasan, Shanu Modi, Komal Jhaveri, Betty Ann Caravella, Sujata Patil, Pier Selenica, Stephen Zamora, Aimee Cowan, Elizabeth Comen, Andy Singh, Anne M. Covey, Michael F. Berger, Clifford A. Hudis, Larry Norton, Rebecca J. Nagy, Justin I. Odegaard, Richard B. Lanman, David B. Solit, Mark E. Robson, Mario E. Lacouture, Edi Brogi, Jorge S. Reis‐Filho, Mary Ellen Moynahan, Maurizio Scaltriti, Sarat Chandarlapaty - Nature Cancer 2020 cited by 162

  23. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

    Authors: Amaia Arruabarrena-Aristorena, Jesper L.V. Mååg, Srushti Kittane, Yanyan Cai, Wouter R. Karthaus, Erik Ladewig, Jane Park, Srinivasaraghavan Kannan, Lorenzo Ferrando, Emiliano Cocco, Sik Yin Ho, Daisylyn Senna Tan, Mirna Sallaku, Fan Wu, Barbara Acevedo, Pier Selenica, Dara S. Ross, Matthew D. Witkin, Charles L. Sawyers, Jorge S. Reis‐Filho, Chandra Verma, Ralf Jauch, Richard P. Koche, José Baselga, Pedram Razavi, Eneda Toska, Maurizio Scaltriti - Cancer Cell 2020 cited by 136

  24. Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care

    Authors: Alexander Penson, Niedzica Camacho, Youyun Zheng, Anna M. Varghese, Hikmat Al‐Ahmadie, Pedram Razavi, Sarat Chandarlapaty, Christina Vallejo, Efsevia Vakiani, Teresa Gilewski, Jonathan E. Rosenberg, Maha Shady, Dana W.Y. Tsui, Dalicia N. Reales, Adam Abeshouse, Aijazuddin Syed, Ahmet Zehir, Nikolaus Schultz, Marc Ladanyi, David B. Solit, David S. Klimstra, David M. Hyman, Barry S. Taylor, Michael F. Berger - JAMA Oncology 2019 cited by 117